Bekir Caglar Celikkaya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bekir Caglar Celikkaya has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Burcin Gungor
2 shared publicationsPakize Canturk
2 shared publications- Ahmet Ozan Kaleci
Sivas Cumhuriyet Üniversitesi
1 shared publication John A Parkinson
1 shared publication- John Andrew Parkinson
Department of Pure and Applied Chemistry, University of Strathclyde, Thomas Graham Building, 295 Cathedral Street, Glasgow, G1 1XL, UK
1 shared publication - Patrícia Rijo
CBIOS-Research Center for Biosciences & Health Technologies, Universidade Lusófona de Humanidades e Tecnologias, 1749-024 Lisbon, Portugal
1 shared publication
Latest Publications
- Open Access
Targeting Clostridioides difficile virulence and antibiotic resistance with multi-target natural products
- 28 June 2026
- Published by Muhammet Dogan in Eurasian Journal of Biological and Chemical Sciences
- Vol. 9 (1) , 43-52
Targeting Antimicrobial-Resistant Diarrhea: Pathogen-Specific and Anti-Virulence Drug Discovery via Molecular Docking
Infectious diarrhea is an increasing global healthcare issue due to the cause of mortality among children under five caused by pathogens such as bacteria, viruses, and parasites. The increasing prevalence of antimicrobial resistance (AMR) has further complicated treatment efforts, highlighting an urgent need for the development of novel therapeutic agents. Antimicrobial chemotherapeutics are often hindered by issues such as gut microbiome disruption and the rising incidence of resistance, highlighting the necessity for pathogen-specific and anti-virulence drug development. This review investigates the wider landscape of AMR-associated diarrhea, focusing on the resistance mechanisms of key pathogens such as Clostridioides difficile and Shigella. It highlights the potential of in silico molecular docking studies as a powerful and efficient computational tool in the drug discovery process by means of accuracy and pathogen-specific drug development. Molecular docking strategies, through profiling ligand-target interactions according to their binding affinity, can help to design promising drug candidates and elucidate their mechanisms of action. Recent studies have shown that the computational docking in screening for inhibitors against drug-resistant targets, paving the way for anti-virulence drug discovery and drug repurposing. This review discusses how some of prospective strategies used by emphasizing the in silico molecular docking methodologies to expedite the development of novel anti-diarrheal drugs with antimicrobial properties. This review outlines how specific AMR targets derived from different microorganisms can be considered as targets for anti-virulence drug development in the context of infectious diarrhea. Therefore, molecular docking approaches could represent a significant advance in combating the growing threat of AMR as a concept.
- 28 June 2026
- Published by Muhammet Dogan in Eurasian Journal of Biological and Chemical Sciences
- Vol. 9 (1) , 43-52
Targeting Antimicrobial-Resistant Diarrhea: Pathogen-Specific and Anti-Virulence Drug Discovery via Molecular Docking
Infectious diarrhea is an increasing global healthcare issue due to the cause of mortality among children under five caused by pathogens such as bacteria, viruses, and parasites. The increasing prevalence of antimicrobial resistance (AMR) has further complicated treatment efforts, highlighting an urgent need for the development of novel therapeutic agents. Antimicrobial chemotherapeutics are often hindered by issues such as gut microbiome disruption and the rising incidence of resistance, highlighting the necessity for pathogen-specific and anti-virulence drug development. This review investigates the wider landscape of AMR-associated diarrhea, focusing on the resistance mechanisms of key pathogens such as Clostridioides difficile and Shigella. It highlights the potential of in silico molecular docking studies as a powerful and efficient computational tool in the drug discovery process by means of accuracy and pathogen-specific drug development. Molecular docking strategies, through profiling ligand-target interactions according to their binding affinity, can help to design promising drug candidates and elucidate their mechanisms of action. Recent studies have shown that the computational docking in screening for inhibitors against drug-resistant targets, paving the way for anti-virulence drug discovery and drug repurposing. This review discusses how some of prospective strategies used by emphasizing the in silico molecular docking methodologies to expedite the development of novel anti-diarrheal drugs with antimicrobial properties. This review outlines how specific AMR targets derived from different microorganisms can be considered as targets for anti-virulence drug development in the context of infectious diarrhea. Therefore, molecular docking approaches could represent a significant advance in combating the growing threat of AMR as a concept.
- Open Access
- 30 December 2025
- Published by Özgür Yayınları
- p. 51-60
Recent Advancements in DNA Gel Electrophoresis on Pharmaceutical Sciences
Gel electrophoresis is a fundamental technique for the separation of charged molecules in pharmaceutical sciences, and it is widely employed in biochemistry, molecular biology, and genetics. The primary methods of electrophoresis include gel electrophoresis, zone electrophoresis, free-flow electrophoresis, and capillary electrophoresis, with gel and capillary electrophoresis being the most prevalent in biological research. In DNA electrophoresis, DNA fragments are separated based on the number of base pairs. This technique utilizes agarose gels, which facilitate the movement of DNA—characterized by a slight negative charge—toward the positive electrode at the gel's end. While the use of electrophoresis has diminished due to advancements in DNA sequencing and polymerase chain reaction (PCR) technologies, gel electrophoresis remains a valuable tool, especially for investigating the interactions of DNA with enzymes. Recent research indicates that scientists are employing agarose gel electrophoresis (AGE) to study enzyme inhibition, structure-activity relationships (SAR), binding studies, pharmaceutical formulation properties, DNA genomics and transcriptomics. Despite the prevalence of newer methodologies, gel electrophoresis continues to provide significant insights in the realm of DNA research. In this section, the recent studies of AGE will be indicated, and the role of AGE in the recent area of pharmaceutical research will be discussed to enlighten the future perspective.
- 30 December 2025
- Published by Özgür Yayınları
- p. 51-60
Open AccessRecent Advancements in DNA Gel Electrophoresis on Pharmaceutical Sciences
Gel electrophoresis is a fundamental technique for the separation of charged molecules in pharmaceutical sciences, and it is widely employed in biochemistry, molecular biology, and genetics. The primary methods of electrophoresis include gel electrophoresis, zone electrophoresis, free-flow electrophoresis, and capillary electrophoresis, with gel and capillary electrophoresis being the most prevalent in biological research. In DNA electrophoresis, DNA fragments are separated based on the number of base pairs. This technique utilizes agarose gels, which facilitate the movement of DNA—characterized by a slight negative charge—toward the positive electrode at the gel's end. While the use of electrophoresis has diminished due to advancements in DNA sequencing and polymerase chain reaction (PCR) technologies, gel electrophoresis remains a valuable tool, especially for investigating the interactions of DNA with enzymes. Recent research indicates that scientists are employing agarose gel electrophoresis (AGE) to study enzyme inhibition, structure-activity relationships (SAR), binding studies, pharmaceutical formulation properties, DNA genomics and transcriptomics. Despite the prevalence of newer methodologies, gel electrophoresis continues to provide significant insights in the realm of DNA research. In this section, the recent studies of AGE will be indicated, and the role of AGE in the recent area of pharmaceutical research will be discussed to enlighten the future perspective.
- Open Access
- 30 December 2025
- Published by Özgür Yayınları
- p. 27-50
Combined Approaches of NMR Spectroscopy in Pharmaceutical Sciences
NMR spectroscopy is extensively utilized across various disciplines of pharmaceutical research. The advancement of magnetic resonance technology has enabled diverse and high-resolution analyses. The importance of data from different sources in pharmaceutical research has increased. NMR spectroscopy is an effective pharmaceutical method with easy application and routine applicability. Another advantage of this method, which allows drug research not only from the chemical but also from the biological and biophysical aspects, is that it is marker-free. Initially utilized at a single level and primarily focused on specific elements such as chemical synthesis and structure-activity elucidation, NMR methodology has evolved to produce multi-level biomolecular and clinically relevant data, including metabolomics and 3D modelling, by integrating it with other instrumental techniques used in pharmaceutical sciences. From this perspective, NMR spectroscopy has found broader applications in pharmaceutical sciences. This section discusses pharmaceutical instrumentation methods combined with NMR technology, their importance, and current publications.
- 30 December 2025
- Published by Özgür Yayınları
- p. 27-50
Open AccessCombined Approaches of NMR Spectroscopy in Pharmaceutical Sciences
NMR spectroscopy is extensively utilized across various disciplines of pharmaceutical research. The advancement of magnetic resonance technology has enabled diverse and high-resolution analyses. The importance of data from different sources in pharmaceutical research has increased. NMR spectroscopy is an effective pharmaceutical method with easy application and routine applicability. Another advantage of this method, which allows drug research not only from the chemical but also from the biological and biophysical aspects, is that it is marker-free. Initially utilized at a single level and primarily focused on specific elements such as chemical synthesis and structure-activity elucidation, NMR methodology has evolved to produce multi-level biomolecular and clinically relevant data, including metabolomics and 3D modelling, by integrating it with other instrumental techniques used in pharmaceutical sciences. From this perspective, NMR spectroscopy has found broader applications in pharmaceutical sciences. This section discusses pharmaceutical instrumentation methods combined with NMR technology, their importance, and current publications.